下肢用末梢血管ステント：企業と競争環境...市場調査レポートについてご紹介

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 12
2 Introduction 13
2.1 Catalyst 14
3 Competitive Assessment 15
3.1 Overview 15
3.1.1 Peripheral Vascular Stent Market 15
3.2 Products 18
3.2.1 Bare Metal Stents 18
3.2.2 Drug-Eluting Stents 102
3.2.3 Covered Stents 109
3.2.4 Bioabsorbable Stents 119
4 Pipeline Products 122
4.1 Overview 122
4.2 Pipeline by Phase of Development 123
4.3 Pipeline Product Profiles – Peripheral Artery Disease 125
4.3.1 Citation Stent 125
4.3.2 MR-Enhanced Stents 126
4.3.3 ArtiStent 127
4.3.4 Hybrid Dynamic Stent 127
4.3.5 Nipro Corporation Peripheral Stent 127
4.3.6 Yukon 128
4.3.7 iCAST 130
4.3.8 Peritoneal-Lined Stents 132
4.3.9 LifeJacket Stent Graft 133
4.3.10 Esprit Bioabsorbable Vascular Scaffold (BVS) 133
4.3.11 Magic Explorer Stent 135
4.3.12 Stanza 137
4.3.13 3D Biotek Bioresorbable Stent 139
4.3.14 Archer Stent 140
4.3.15 ART Stent 141
4.3.16 Amaranth Bioabsorbable Scaffold 141
4.3.17 TephaFLEX Absorbable Peripheral Stent 141
4.3.18 Zorion Medical Stent 142
4.3.19 Summary 142
5 Current and Future Players 143
5.1 Overview 143
5.2 Trends in Corporate Strategy 144
5.3 Company Profiles 147
5.3.1 Abbott Vascular 147
5.3.2 Amaranth Medical 149
5.3.3 Arterial Remodeling Technologies 151
5.3.4 Atrium Medical Corporation 153
5.3.5 Bard Peripheral Vascular (C.R. Bard) 155
5.3.6 Biotronik 157
5.3.7 Boston Scientific Corporation 159
5.3.8 3D Biotek 161
5.3.9 480 Biomedical 163
5.3.10 Cook Medical 165
5.3.11 Cordis Corporation (Johnson & Johnson) 167
5.3.12 CorInnova 169
5.3.13 Covidien 171
5.3.14 Cytograft Tissue Engineering 173
5.3.15 Flexible Stenting Solutions 175
5.3.16 IDEV Technologies 177
5.3.17 Kyoto Medical Planning 179
5.3.18 Medtronic 182
5.3.19 Nexeon Stent 185
5.3.20 Nipro Corporation 187
5.3.21 NovoStent Corporation 189
5.3.22 OptiMed 191
5.3.23 PeriTec Biosciences 193
5.3.24 Synergy Flow 195
5.3.25 Tepha 197
5.3.26 Terumo Corporation 199
5.3.27 TissueGen 201
5.3.28 Translumina 203
5.3.29 Vascular Concepts 205
5.3.30 Veryan Medical 207
5.3.31 VueKlar Cardiovascular 209
5.3.32 W.L. Gore & Associates 211
5.3.33 Zorion Medical 213
6 Appendix 215
6.1 Bibliography 215
6.2 Abbreviations 238
6.3 Report Methodology 241
6.3.1 Overview 241
6.3.2 Coverage 241
6.3.3 Secondary Research 241
6.3.4 Forecasting Methodology 242
6.4 Physicians and Specialists Included in this Study 243
6.5 Physician Survey 245
6.6 About the Authors 245
6.6.1 Analysts 245
6.6.2 Global Head of Healthcare 246
6.7 About MediPoint 247
6.8 About GlobalData 247
6.9 Contact Us 247
6.10 Disclaimer 247